Picture Berlin Partner Health Capital Computational Biology 2022 650x100px
Organisation › Details

Brammer Bio LLC

Brammer Bio provides clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patients' health. Brammer is Helping to Cure®. Brammer is owned by Ampersand Capital Partners, the only institutional investor in the company, and its founders. *


Period Start 2017-12-09 existent
  Group Thermo Fisher (Group)
Products Industry contract manufacturing (BCS)
  Industry 2 cell therapy
Region Region Cambridge, MA
  Country United States (USA)
  Street 250 Binney Street
  City 02142 Cambridge, MA
    Address record changed: 2020-12-02
Basic data Employees E: 501 to 1,000 (2019-03-24)
  Currency USD
  Annual sales 250,000,000 (revenue, expected (2019) 2019-12-31)
    * Document for �About Section�: Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA.
Record changed: 2020-03-16


Picture EBD Group BIO-Europe 2022 Leipzig 650x200px

More documents for Thermo Fisher (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px

» top